<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>2c5d9f58-1b52-499e-ae2a-14eb424a1853</id>
  <name>ARST1921 Nirogacestat Peds Take Home Medication Order Group</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ï»© Technical Traceability</key>
        <value>{~AHSID~2c5d9f58-1b52-499e-ae2a-14eb424a1853~NAME~ARST1921 Nirogacestat Peds Take Home Medication Order Group}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Provider Communication&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;BSA-based dosing table for dose rounding (nearest 10 mg). The dose of nirogacestat in the table is expressed as final dose in mg to be administered.&lt;/p&gt;&lt;p&gt;&amp;nbsp;See section 5.0 for Dose Modifications based on Toxicities.&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;table&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;1&quot; align=&quot;center&quot; style=&quot;width:463px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; style=&quot;width:460px&quot;&gt;&lt;p&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; Nirogacestat&lt;/p&gt;&lt;p&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;90 mg/m2/dose PO BID&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;BSA&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;Dose&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;0.3 - 0.38&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;30 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;0.39 - 0.5&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;40 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;0.51 - 0.61&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;50 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;0.62 - 0.72&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;60 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;0.73 - 0.83&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;70 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;0.84 - 0.94&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;80 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;0.95 - 1.05&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;90 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;1.06 - 1.16&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;100 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;1.17 - 1.27&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;110 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;1.28 - 1.38&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;120 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;1.39 - 1.5&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;130 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;1.51 - 1.61&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;140 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Greater than and equal to 1.62&lt;/td&gt;&lt;td style=&quot;width:236px&quot;&gt;150 mg BID&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Provider Communication&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;PLACEHOLDER; INV Nirogacestat capsule, PO&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;Dose: 90 mg/m2/dose PO BID (maximum dose 150 mg PO BID)&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp; Set to Normal&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;PLACEHOLDER; INV Nirogacestat capsule, PO&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Take-Home Medications">
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3f7a5553-1129-4bba-b68e-b9e6ee0be16d" concept_name="PC Provider Communication Order" max="1" path="/items" name="Provider Communication"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fa80ca89-b938-4053-b4ab-6eaf57409b6f" concept_name="PLACEHOLDER Order Item" max="1" path="/items" name="PLACEHOLDER; INV Nirogacestat capsule, PO"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
</template>